GlassScriptPhysician profile
Alberto Zarak
NPI 1659650034
$4,895.99
in general payments reported to CMS, 2019-2025
23 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $343 · 2021: $2,162 · 2022: $1,013 · 2023: $373 · 2024: $577 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,246.45 | 2021-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $908.79 | 2019-2022 | |
| Baxter Healthcare | $462.37 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $446.05 | 2021-2022 | |
| Acera Surgical, INC. | $368.72 | 2023-2025 | Restrata Wound Matrix |
| Novo Nordisk INC | $203.22 | 2022-2025 | Wegovy |
| Innovation Technologies INC | $188.15 | 2024 | Irrisept |
| Davol INC. | $186.77 | 2022 | |
| Medtronic, INC. | $186.03 | 2021-2023 | Illumisite |
| Medical Device Business Services, INC. | $118.81 | 2019 | |
| Abbott Laboratories | $103.68 | 2024 | Esprit |
| Redhill Biopharma INC. | $92.74 | 2020-2022 | |
| Intra-Sana Laboratories | $80.35 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Lexington Medical, INC. | $72.22 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Covidien LP | $37.67 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $33.50 | 2025 | Contrave |
| Tela Bio, INC. | $31.70 | 2020-2022 | |
| Cook Medical LLC | $28.54 | 2019 | |
| Masimo Corporation | $23.82 | 2024 | |
| Abbvie INC. | $23.49 | 2022 | |
| Standard Bariatrics, INC. | $22.77 | 2022 | |
| Vivus LLC | $17.50 | 2024 | Pancreaze |
| Janssen Pharmaceuticals, INC | $12.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Zarak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.